Search filters
Termination TerugBetaalRegeling Fampyra®

Termination TerugBetaalRegeling Fampyra®

08/11/2019

Fampyra® is fully reimbursement from the 1st of September 2019. For this reason the co-payment for Fampyra ended per August 31,...

Launch of TerugBetaalRegeling Veltassa®

Launch of TerugBetaalRegeling Veltassa®

18/09/2019

The health insurer does not fully reimburse Veltassa® 8.4g. The producer of this medicine has therefore asked TBR Nederland to...

Amendment to TerugBetaalRegeling Forxiga® and Xigduo®Amendment to TerugBetaalRegeling Forxiga® and Xigduo®

Amendment to TerugBetaalRegeling Forxiga® and Xigduo®

06/09/2019

The health insurer does not yet reimburse this medication as monotherapy or for specific combination treatment. The producer of...

Launch of TerugBetaalRegeling Lokelma®

Launch of TerugBetaalRegeling Lokelma®

01/09/2019

The health insurer does not fully reimburse Lokelma® 5g and 10g. The producer of this medicine has therefore asked TBR Nederland...

Relaunch of TerugBetaalRegeling Plenadren®

Relaunch of TerugBetaalRegeling Plenadren®

12/08/2019

The health insurer does not fully reimburse Plenadren® 5mg and 20mg. The producer of this medicine has therefore asked TBR...

You are currently offline. Some pages or content may fail to load.